These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 147797)

  • 21. Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21.
    Feaster WW; Kwok LW; Epstein CJ
    Am J Hum Genet; 1977 Nov; 29(6):563-70. PubMed ID: 145179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of overexpression of the cytoplasmic copper-zinc superoxide dismutase on the survival of neurons in vitro.
    Schwartz PJ; Coyle JT
    Synapse; 1998 Jul; 29(3):206-12. PubMed ID: 9635890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The level of superoxide dismutase in erythrocytes of children with Down syndrome (trisomy G and unbalanced translocation G 21/22).
    Kedziora J; Jeske J; Witas H; Bartosz G; Leyko W
    Acta Biol Med Ger; 1977; 36(5-6):779-82. PubMed ID: 146388
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipid peroxides in blood plasma and enzymatic antioxidative defence of erythrocytes in Down's syndrome.
    Kedziora J; Bartosz G; Gromadzińska J; Skłodowska M; Wesowicz W; Scianowski J
    Clin Chim Acta; 1986 Feb; 154(3):191-4. PubMed ID: 2937579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome.
    Porstmann T; Wietschke R; Cobet G; Lorenz K; Grunow R; Jahn S; Bollmann R; Stamminger G; von Baehr R
    Hum Genet; 1990 Aug; 85(3):362-6. PubMed ID: 2144256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The levels of superoxide dismutase, catalase, and carbonic anhydrase in erythrocytes of patients with Down's syndrome.
    Ohno H; Lizuka S; Kondo T; Yamamura K; Sekiya C; Taniguchi N
    Klin Wochenschr; 1984 Mar; 62(6):287-8. PubMed ID: 6232420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rapid and sensitive enzyme immunoassay for Cu/Zn superoxide dismutase with polyclonal and monoclonal antibodies.
    Porstmann T; Wietschke R; Schmechta H; Grunow R; Porstmann B; Bleiber R; Pergande M; Stachat S; von Baehr R
    Clin Chim Acta; 1988 Jan; 171(1):1-10. PubMed ID: 2964951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial dysfunction and Down's syndrome.
    Arbuzova S; Hutchin T; Cuckle H
    Bioessays; 2002 Aug; 24(8):681-4. PubMed ID: 12210526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down's syndrome in Hyderabad, India.
    Isaac GS; Krishnamurty PS; Reddy YR; Ahuja YR
    Acta Anthropogenet; 1985; 9(4):256-60. PubMed ID: 2967078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superoxide dismutase (SOD) as a potential inhibitory mediator of inflammation via neutrophil apoptosis.
    Yasui K; Kobayashi N; Yamazaki T; Agematsu K; Matsuzaki S; Ito S; Nakata S; Baba A; Koike K
    Free Radic Res; 2005 Jul; 39(7):755-62. PubMed ID: 16036355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical Down syndrome and partial trisomy 21.
    Jenkins EC; Duncan CJ; Wright CE; Giordano FM; Wilbur L; Wisniewski K; Sklower SL; French JH; Jones C; Brown WT
    Clin Genet; 1983 Aug; 24(2):97-102. PubMed ID: 6225574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice.
    Avraham KB; Sugarman H; Rotshenker S; Groner Y
    J Neurocytol; 1991 Mar; 20(3):208-15. PubMed ID: 1828079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive copper-zinc superoxide-dismutase (SOD-1) in mosaic trisomy 21 and normal subjects.
    Baeteman MA; Mattei MG; Baret A; Mattei JF
    Acta Paediatr Scand; 1984 May; 73(3):341-4. PubMed ID: 6234750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of Down's syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes.
    Groner Y; Elroy-Stein O; Bernstein Y; Dafni N; Levanon D; Danciger E; Neer A
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():381-93. PubMed ID: 2953545
    [No Abstract]   [Full Text] [Related]  

  • 35. Down's syndrome phenotype and autosomal gene inactivation in a child with presumed (X;21) de novo translocation.
    Taysi K; Sparkes RS; O'Brien TJ; Dengler DR
    J Med Genet; 1982 Apr; 19(2):144-8. PubMed ID: 6210775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
    Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
    Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper/zinc superoxide dismutase activity in trisomy 21 by translocation.
    Garber P; Sinet PM; Jerome H; Lejeune J
    Lancet; 1979 Oct; 2(8148):914-5. PubMed ID: 91020
    [No Abstract]   [Full Text] [Related]  

  • 38. Overexpression of copper-zinc superoxide dismutase in trisomy 21.
    De La Torre R; Casado A; López-Fernández E; Carrascosa D; Ramírez V; Sáez J
    Experientia; 1996 Sep; 52(9):871-3. PubMed ID: 8841514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aging of nervous system and S-100 proteins].
    Kato K; Asano T; Inagaki T; Yamamoto T; Sato T
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):287-92. PubMed ID: 2145454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain.
    Brooksbank BW; Balazs R
    Brain Res; 1984 Sep; 318(1):37-44. PubMed ID: 6237715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.